Dosage ; Intravenous infusion, 2-5mcg/kg/minute initially
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Dopamine | Fresenius | Surgipharm Ltd | 50mg | 100 | Tablet | per tablet | KES 12090 |
| Dopamine, | Fresenius | Surgipharm Ltd | 200mg | 50ml | Injection | per vial | KES 3,179.00 |
| Dopmin | Orion | Universal Corporation Ltd | 40mg | 25ml | Injection | per vial | KES 2,250.00 |
|
Dopamine More info |
|
|---|---|
| Mode Of Action | Inotropic sympathomimetic |
| Drug Indication | Cardiogenic shock, septic shock, cardiomyopathies, cardiac surgery, infarction. |
| Precautions | Continuous monitoring of ECG and blood pressure, hypovolemia to be corrected first, subaortic stenosis. |
| Contra-Indications | Phaeochromocytoma, tachyarrhythmia |
| Side Effects | Hypotension or hypertension, tachycardia, nausea and vomiting, peripheral vasoconstriction |
| Dosage | Intravenous infusion, 2-5mcg/kg/minute initially |
| Pregnancy Category | Category B3 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Inotropic sympathomimetics
harmacologic Category Adrenergic Agonist Agent Dosing: Adult Hemodynamic support: I.V. infusion: 1-5 mcg/kg/minute up to 50 mcg/kg/minute, titrate to desired response; infusion may be increased by 1-4 mcg/kg/minute at 10- to 30-minute intervals until optimal response is obtained Note: If dosages >20-30 mcg/kg/minute are needed, a more direct-acting vasopressor may be more beneficial (ie, epinephrine, norepinephrine). Hemodynamic effects of dopamine are dose dependent: Low-dose: 1-5 mcg/kg/minute, increased renal blood flow and urine output Intermediate-dose: 5-15 mcg/kg/minute, increased renal blood flow, heart rate, cardiac contractility, and cardiac output High-dose: >15 mcg/kg/minute, alpha-adrenergic effects begin to predominate, vasoconstriction, increased blood pressure Dosing: Pediatric Hemodynamic support: I.V. infusion: Children: 1-20 mcg/kg/minute, maximum: 50 mcg/kg/minute continuous infusion, titrate to desired response. Dosing: Geriatric Refer to adult dosing. |